Join the India Equity Telegram Group for analysis, updates and results

BALPHARMA has declared results for the period ended Sep 2021.

Quarterly Results

[s2If !current_user_can(access_s2member_level1)] Register and Login below to read result analysis [lwa][/s2If] [s2If current_user_can(access_s2member_level1)]

• Sales for period ended Sep 2021 is Rs 67.17 cr compared to Rs 64.56 cr for period ended Sep 2020, a rise of 4.0%
• Operating Profits reported at Rs 6.33 cr for period ended Sep 2021 vis-vis 7.11 for period ended Sep 2020 .
• Operating Margins contracted -158.9 bps for period ended Sep 2021 vis-vis Sep 2020 .
• The EPS for Sep 2021 was Rs 0.93 compared to Rs 1.09 for previous quarter ended Jun 2021 and Rs 0.3 for Sep 2020
• The stock is trading at Rs 94.75 and a market cap of Rs 140 cr

[/s2If]

Trading Chart

Further analysis and Full Company Research with investing scores is available here: BALPHARMA

Join BharatEquity Telegram Channel for updated India results, analysis and News
Join Our Twitter